Journal of Clinical Endocrinology & Metabolism, Vol 71, 618-621, Copyright © 1990 by Endocrine Society

ARTICLES

Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism

AH Perelman, RL Johnson, RD Clemons, HJ Finberg, WH Clewell and L Trujillo
Pediatric Endocrinology Section, Phoenix Children's Hospital, Arizona 85006.

Newborn screening programs for the detection of congenital hypothyroidism have dramatically shortened the time before treatment is begun. However, concern still exists about central nervous system sequelae which may persist due to a period of untreated intrauterine hypothyroidism. Presence of polyhydramnios led to the ultrasound diagnosis of a fetal goiter. Hypothyroidism was confirmed at 34 weeks gestation by percutaneous fetal blood sampling, which revealed an elevated TSH (186 mU/L) and a low T4 (19.3 nmol/L). Intraamniotic fluid injections of 500 micrograms levothyroxine sodium (T4) every 10-14 days increased fetal serum T4 (59.2 nmol/L), decreased fetal serum TSH (14 mU/L), decreased amniotic fluid TSH, and decreased the size of the fetal goiter. The infant was born at term without perinatal complications. Thyroid function studies on cord blood were normal (T4, 109.4 nmol/L; TSH, 1.3 mU/L), and the infant was discharged on oral T4. Follow-up examination at age 6 weeks revealed that the infant was developmentally normal and clinically and chemically euthyroid. Intrauterine T4 therapy can suppress fetal TSH and treat fetal hypothyroidism despite hypothyroid levels of serum T3. Highly sensitive TSH assays may allow the use of amniotic fluid TSH as a marker for fetal hypothyroidism.

This article has been cited by other articles:

				M. J. E. Kempers, A. S. P. van Trotsenburg, D. A. van Tijn, E. Bakker, B. M. Wiedijk, E. Endert, J. J. M. de Vijlder, and T. Vulsma Disturbance of the Fetal Thyroid Hormone State Has Long-Term Consequences for Treatment of Thyroidal and Central Congenital Hypothyroidism J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4094 - 4100. [Abstract] [Full Text] [PDF]

				P. K. Singh, C. A. Parvin, and A. M. Gronowski Establishment of Reference Intervals for Markers of Fetal Thyroid Status in Amniotic Fluid J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4175 - 4179. [Abstract] [Full Text] [PDF]

				P. Caron, C. M. Moya, D. Malet, V. J. Gutnisky, B. Chabardes, C. M. Rivolta, and H. M. Targovnik Compound Heterozygous Mutations in the Thyroglobulin Gene (1143delC and 6725G->A [R2223H]) Resulting in Fetal Goitrous Hypothyroidism J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3546 - 3553. [Abstract] [Full Text] [PDF]

				D. A. KOUTRAS Thyroidopathies Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 77 - 88. [Abstract] [Full Text] [PDF]

				C. Asteria, O. Rajanayagam, T. N. Collingwood, L. Persani, R. Romoli, D. Mannavola, P. Zamperini, F. Buzi, F. Ciralli, V. K. K. Chatterjee, et al. Prenatal Diagnosis of Thyroid Hormone Resistance J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 405 - 410. [Abstract] [Full Text]

				R. Bajoria, T. A. Ryder, and N. M. Fisk Transport and Metabolism of Thyrotrophin-Releasing Hormone Across the Fetal Membrane J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3399 - 3407. [Abstract] [Full Text] [PDF]